SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage ...
Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical trial of SENTI-202 maintaining remission ...
Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical trial of SENTI-202 maintaining remission - - Strengthened ...
Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical trial of SENTI-202 maintaining remission ...
Explore Senti Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SNTI. US Stock Futures Dip As Dollar Slides And Treasuries Rise After S&P Hits ...
After hours: March 25 at 4:05:12 p.m. EDT Loading Chart for SNTI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback